School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Cipla Limited CIPLA.NS

Healthcare · Drug Manufacturers - Specialty & Generic

₹1,301last close 2026-10-09 · delayed data

Trailing returns

1M-4.56%
3M-9.73%
6M+7.25%
1Y-13.21%
5Y+47.85%

Basis: Adjusted daily closes.

What it does

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Open CIPLA.NS in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies